Polaris Financial Partners’s AbbVie ABBV Stock Holding History

Polaris Financial Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$205K	Buy	+778	New	+$199K	0.09%	85

Other funds holding ABBV

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Violich Capital Management San Francisco, California $927M AUM 28.93% 1-Year Est. Return

Coastline Trust Providence, Rhode Island $1.07B AUM 21.73% 1-Year Est. Return

CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return

Montecito Bank & Trust Santa Barbara, California $660M AUM 18.73% 1-Year Est. Return

First Financial Bank - Trust Division Hamilton, Ohio $1.39B AUM 15.59% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Boltwood Capital Management Walnut Creek, California $443M AUM 17.72% 1-Year Est. Return

GoalVest Advisory New York $578M AUM 17.41% 1-Year Est. Return

Parrish Capital Kennesaw, Georgia $103M AUM 35.11% 1-Year Est. Return

Polaris Financial Partners's ABBV Position: Q3 2026 in Review

Polaris Financial Partners opened a new position in AbbVie (ABBV) in Q3 2026: 778 shares worth $205K. The stake represents 0.09% of the portfolio and ranks #85 among its holdings.

25 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Polaris Financial Partners held 778 shares of AbbVie worth $205K as of Q3 2026.
AbbVie was a new Polaris Financial Partners position in Q3 2026.
AbbVie made up 0.09% of Polaris Financial Partners's portfolio in Q3 2026, its #85 holding.
25 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Polaris Financial Partners's 13F filing for Q3 2026, filed 2 Oct 2026.